Clonal hematopoiesis in cancer
- 7 February 2020
- journal article
- review article
- Published by Elsevier BV in Experimental Hematology
- Vol. 83, 105-112
- https://doi.org/10.1016/j.exphem.2020.02.001
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceThe New England Journal of Medicine, 2014
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesThe New England Journal of Medicine, 2014
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature, 2014
- Age-related mutations associated with clonal hematopoietic expansion and malignanciesNature Medicine, 2014
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerNature, 2012
- Germline mutations in the DNA damage response genesBRCA1,BRCA2,BARD1andTP53in patients with therapy related myeloid neoplasmsJournal of Medical Genetics, 2012
- Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell TransplantationCancer Discovery, 2012
- INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCERMediterranean Journal of Hematology and Infectious Diseases, 2011
- Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)Breast Cancer Research and Treatment, 2009
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core DomainCancer Cell, 2009